The Yin and Yang of nitric oxide: Reflections on the physiology and pathophysiology of NO·

Head and Neck

Volumn 22, Issue 1, 2000, Pages 71-83

  Bentz, Brandon G ^a   Simmons, Richard L ^b   Haines III, G Kenneth ^a   Radosevich, James A ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

Head and neck cancer; Nitric oxide; Oxidation reduction; Pathophysiology; Physiology

Indexed keywords

ARGININE; CITRULLINE; CYCLIC GMP; DNA; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

CHEMICAL ANALYSIS; CHRONIC INFLAMMATION; DNA DAMAGE; ENZYMOLOGY; HEAD AND NECK SURGERY; MACROPHAGE; OXIDATION REDUCTION REACTION; PATHOPHYSIOLOGY; PHYSIOLOGY; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; SIGNAL TRANSDUCTION;

EID: 0033989030     PISSN: 10433074     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0347(200001)22:1<71::AID-HED11>3.0.CO;2-G     Document Type: Review

References (125)

1. Stuehr DJ, Marietta MA. Mammalian nitrate biosynthesis: mouse macrophages produce nitrite and nitrate in response to Eschericlhia coli lipopolysaccharide. Proc Natl Acad Sci USA 1985;82:7738-7742.
2. Culotta E, Koshland DE. NO news is good news. Science 1992;258:1862-1865.
3. Nathan C, Xie Q. Nitric oxide synthases: roles, tolls, and controls. Cell 1994;78:915-918.
4. Koppenol WH, Traynham JG. Say NO to nitric oxide: nomenclature for nitrogen-and oxygen-containing compounds. Meth Enzym 1996;268:3-7.
5. Hall AV, Antoniou H, Wang Y, et al. Structural organization of the human nitric oxide synthase gene (NOS 1). J Biol Chem 1994;269:33082-33090.
6. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-13728.
7. Xie QW, Nathan C. The high-output nitric oxide pathway: role and regulation. J Leuk Biol 1994;56:576-582.
8. Heiss LN, Lancaster JR, Corbett JA, et al. Epithelial autotoxicity of nitric oxide: role in respiratory cytopathology of pertussis. Proc Natl Acad Sci USA 1994;91: 267-270.
9. Harrison DG, Venema RC, Arnal JF, et al. The endothelial cell nitric oxide synthase: is it really constitutively expressed? Agents and Actions 1995;45:107-117.
10. Bentz BG, Barnes MN, Haines GK, et al. Cytoplasmic localization of endothelial constitutive nitric oxide synthase in endometrial carcinomas. Tumor Biol 1997;18: 290-300.
11. Hortelano S, Genaro AM, Bosca L. Phorbol esters induce nitric oxide synthase activity in rat hepatocytes. antagonism with the induction by lipopolysaccharide. J Biol Chem 1992;267:24937-24940.
12. Marietta MA. Nitric oxide synthase structure and mechanism. J Biol Chem 1993;268:12231-12234.
13. Korth H, Sustmann R, Thater C, et al. On the mechanism of the nitric oxide synthase-catalyzed conversion of Nω-hydroxy-L-arginine to citrulline and nitric oxide. J Biol Chem 1994;269:17776-17779.
14. Marietta MA. Nitric oxide synthase: aspects concerning structure and catalysis. Cell 1994;78:927-930.
15. Stuehr DJ, Kwon NS, Nathan CF, et al. Nω-hydroxy-L-arginine is an intermediate in the biosynthesis of nitric oxide from L-arginine. J Biol Chem 1991;269:15147-15153.
16. Pufahl RA, Nanjappan PG, Woodard RW, et al. Mechanistic probes of N-hydroxylation of L-arginine by the inducible nitric oxide synthase from murine macrophages. Biochemistry 1992;31:6822-6828.
17. Xie QW, Whisnant R, Nathan C. Promoter of the mouse gene encoding calcium-independent nitric oxide synthase confers inducibility by interferon gamma and bacterial lipopolysaccharide. J Exp Chem 1993;177: 1779-1784.
18. Kiode M, Kawahara Y, Nakayama I, et al. Cyclic AMP-elevating agents induce an inducible type of nitric oxide synthase in cultured vascular smooth muscle cells. Synergism with the induction elicited by inflammatory cytokines. J Biol chem 1993;268:24959-24966.
19. Perrella JA, Yoshizumi M, Fen Z, et al. Transforming growth factor β1, but nor dexamethasone, down-regulates nitric-oxide synthase mRNA after induction by interleukin-1β in rat smooth muscle cells. J Biol chem 1994;269:14595-14600.
20. Vodovotz Y, Bogan C, Paik J, et al. Mechanisms of suppression of macrophage nitric oxide release by transforming growth factor beta. J Exp Med 1993;178: 605-613.
21. Nathan C, Xie QW. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-13728.
22. Busconi L, Michel T. Endothelial nitric oxide synthase: N-terminal myristoylation determined subcellular localization. J Biol Chem 1993;268:8410-8413.
23. Nathan C, Xie Q. Regulation of biosynthesis of nitric oxide. J Biol Chem 1994;269:13725-13728.
24. Marietta MA. Nitric oxide synthase; aspects concerning structure and catalysis. Cell 1994;78:927-930.
25. Abu-Soud HM, Steuhr DJ. Nitric oxide synthases reveal a role for calmodulin in controlling electron transfer. Proc Natl Acad Sci USA 1993;90:10769-10772.
26. Vodovotz Y, Kwon NS, Pospichil M, et al. Inacctivation of nitric oxide synthase after prolonged incubation of mouse macrophages with IFN-gamma and bacterial lipopolysaccharide. J Immunol 1994;152:4110-4118.
27. Rengasamy A, Johns RA. Regulation of nitric oxide synthase by nitric oxide. Mol Pharmacol 1993;44:124-128.
28. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994;78:931-936.
29. Lancaster JR. Stimulation of the diffusion and reaction of endogenously produced nitric oxide. Proc Natl Acad Sci USA 1994;91:8137-8141.
30. Beckman JS, Crow JP. Pathologic implications of nitric oxide, superoxide, and peroxynitrite formation. Biochem Soc Trans 1993;21:330-334.
31. Stamler JS. Redox signaling: nitrosylation and related target interactions of nitric oxide. Cell 1994;78:931-936.
32. Schmidt HHHW, Lohmann S, Walter U. The nitric oxide and cGMP signal transduction system: regulation and mechanism of action. Biochem Biophys Acta 1993;1178: 153-175.
33. Schreck R, Baeuerle PA. A role for oxygen radicals as second messengers. Trends Cell Biol 1991;1:39-43.
34. Stamler JS, Singel DJ, Loscalzo J. Biochemistry of nitric oxide and its redox-activated forms. Science 1992;258: 1898-1902.
35. Gibson QH, Roughton FJ. The determination of the velocity constants of four successive reactions of carbon monoxide with sheep haemoglobin. Proc r Soc, Ser B, Biol Sc, Lond 1957;146:206-224.
36. Hobbs AJ, Ignarro LJ. Nitric oxide-cyclic GMP signal transduction system. Meth Enzymol 1996;269:134-148.
37. Niroomand F, Rössle R, Mülsch A, et al. Under anaerobic conditions, soluable guanylate cyclase is specifically stimulated by glutathione. Biochem Biophys Res Comm 1989;161:75-80.
38. Khatsenko OG, Gross SS, Rifkind AR, et al. Nitric oxide is a mediator of the decrease in cytochrome P450-dependent metabolism caused by immunostimulants. Proc Natl Acad Sci USA 1993;90:11147-11151.
39. Brüne B, Mohr S, Meßmer UK. Protein thiol modification and apoptotic cell death as cGMP-independent nitric oxide (NO) signaling pathways. Rev Physiol Biochem Pharmacol 1995;127:1-30.
40. Schuppe-Koistinen I, Moldeus P, Bergman T, et al. S-thiolation of human endothelial glyceraldehyde-3-phosphate dehydrogenase after hydrogen peroxide treatment. Eur J Biochem 1994;221:1033-1037.
41. Stamler JS, Simon DI, Osborne JA, et al. S-nitrosylation of proteins with nitric oxide: synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992;89:444-448.
42. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;266:4244-4250.
43. Meister A. Glutathione, ascorbate and cellular protection. Cancer Res 1994;54:1969s-1975s.
44. Droge W, Schulze-Osthoff K, Mihm S, et al. Function of glutathione and glutathione disulfide in immunology and immunopathology. FASEB J 1994;8:1131-1138.
45. Duhe RJ, Nielsen MD, Dittman AH, et al. Oxidation of critical cysteine residues of type I adenylyl cyclase by o-iodosobenzoate or nitric oxide reversibly inhibits stimulation by calcium and calmodulin. J Biol Chem 1994;269:7290-7296.
46. Gopalakrishna R, Chen ZH, Gundimeda U. Nitric oxide and nitric-oxide-generating agents induce a reversible inactivation of protein kinase C activity and phorbol ester binding. J Biol Chem 1993;268:27180-27185.
47. Stamler JS, Simon DI, Osborne JA, et al. S-nitrosylation of proteins with nitric oxide: Synthesis and characterization of biologically active compounds. Proc Natl Acad Sci USA 1992;89:444-448.
48. Simon DI, Mullins ME, Jia L, et al. Polynitrosylated proteins: characterization, bioactivity, and functional consequences. Proc Natl Acad USA 1996;93:4736-4741.
49. Laval F, Wink DA. Inhibition by nitric oxide of the repair protein, O6-methylguanine-DNA-methyltransferase. Carcinogenesis 1994;15:443-447.
50. Stadler J, Billiar TR, Curran RD, et al. Effects of exogenous and endogenous nitric oxide on mitochondrial respiration of rat hepatocytes. Am J Physiol 1991;260: C910-C916.
51. Drapier JC, Hibbs JB. Differentiation of murine macrophages to express nonspecific cytotoxicity for tumor cells results in L-arginine-dependent inhibition of mitochondrial iron-sulfur enzymes in the macrophage effector cells. J Immunol 1988;140:2829-2838.
52. Hausladen A, Fridovich I. Superoxide and peroxynitrite inactivate aconitase, nitric oxide does not. J Biol Chem 1994;269:29405-2948.
53. Stevens TH, Brudvig GW, Bocian DF, et al. Structure of cytochrome a3-Cu3 couple in cytochrome c oxidase as revealed by nitric oxide binding studies. Proc Natl Acad Sci USA 1979;76:3320-3324.
54. O'Halloran TV. Transition metals in control of gene expression.Science 1993;261:715-730.
55. Drapier JC, Hirling H, Wietzerbin J, et al. Biosynthesis of nitric oxide activates iron regulatory factor in macrophages. EMBOJ J 1993;12:3643-3649.
56. Di Rosa M, Ialenti A, Ianaro A, et al. Interaction between nitric oxide and cyclooxygenase pathways. Prostagl Leukot Essent Fatty Acids 1996;54:229-238.
57. Salvemini D, Masferrer JL. Interactions of nitric oxide with cycloxygenase in vitro, ex vivo, and in vivo studies. Meth Enzymol 1996;269:12-25.
58. Salvemini D, Misko TP, Masferrer JL, et al. Nitric oxide activates cyclooxygenase enzymes. Proc Natl Acad USA 1993;90:7240-7244.
59. Zhang J, Dawson VL, Dawson TM, et al. Nitric oxide activation of poly (ADP-ribose) synthetase in neurotoxicity. Science 1994;263:687-689.
60. Hidalgo E, Demple B. An iron-sulfur center essential for transcriptional activation by the redox sensing Sox R protein. EMBO J 1994;13:138-146.
61. Storz G, Tartaglia LA, Ames BN. Transcriptional regulator of oxidative stress-inducible genes: direct activation by oxidation. Science 1990;2113:189-194.
62. Radi R, Beckman JS, Bush KM, et al. Peroxynitrite oxidation of sulfhydryls. The cytotoxic potential of superoxide and nitric oxide. J Biol Chem 1991;268:17655-17658.
63. Gaston B, Reilly J, Drazen JM, et al. Endogenous bronchodilator S-nitrosothiols in human airways. Proc Natl Acad USA 1993;90:10957-10961.
64. Beckman JS, Beckman TW, Chen J, et al. Apparent hydroxyl radical production by peroxinitrite: implications for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci USA 1990;87:1620-1624.
65. Bittrich H, Matik AK, Kraker I, et al. NO2-induced DNA single strand breaks are inhibited by antioxidative vitamins in V79 cells. Chem-Biol Interact 1993;86:199-211.
66. Noronha-Dutra AA, Epperlein MM, Woold N. Reaction of nitric oxide synthase with hydrogen peroxide to produce potentially cytotoxic singlet oxygen as a model for nitric oxide-mediated killing. FEBS Lett 1993;321:59-62.
67. Mirvish SS. Role of N-nitroso compound (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal, and bladder cancer and the contribution of known exposure to NOC. Cancer Lett 1995;93:17-113.
68. Langrehr JM, Hoffman RA, Lancaster JR, et al. Nitric oxide-a new endogenous immunomodulator. Transplantation 1993;55:1205-1212.
69. Nathan C, Hibbs JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opinion Immunol 1991;3:65-70.
70. Nathan CF, Hibbs JB. Role of nitric oxide in macrophage antimicrobial activity [review]. Curr Opinion Immunol 1991;3:65-70.
71. De Kimpe SJ, Bryan L, Tabaqchali S, et al. Induction of nitric-oxide by Gram-positive organisms in murine macrophages and rat oartic smooth muscle cells. J Endothel Res 1995;3:s53.
72. Hibbs JB, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol 1987:138:550-565.
73. Meßmer UK, Ankarcrona M, Nicotera P, et al. P53 expression in nitric oxide-induced apoptosis. FEBS Lett 1994;355:23-26.
74. Heiss LN, Lancaster JR, Corbett JA, et al. Epithelial autoxicity of nitric oxide: role in the respiratory cytopathology of pertussis. Proc Natl Acad Sci USA 1994;91: 267-270.
75. Henry Y, Ducrocq C, Drapier J-C, et al. Nitric oxide, a biological effector: electron paramagnetic resonance detection of nitrosyl-iron-protein complexes in whole cells. Eur Biophys J 1991;20:1-15.
76. Lepoivre M, Chenais B, Yapo A, et al. Alteration of ribonucleotide reductase activity following induction of the nitrite-generating pathway in adenocarcinoma cells. J Biol Chem 1990;265:14143-14149.
77. Bowlin TL, McKown BJ, Sunkara PS. Increased ornithine decarboxylase activity and polyamine biosynthesis are required for optimal cytolytic T lymphocyte induction. Cell Immunol 1987;105:110-117.
78. Garg UC, Hassid A. Nitric oxide decreases cytosolic free calcium in BALB/c 3T3 fibroblasts by a cyclic GMP-independent mechanism. J Biol Chem 199;266:9-12.
79. Ochoa J, Udekwu A, Billiar T, et al. Nitrogen oxide levels in patients after trauma and during sepsis. Ann Surg 1991;214:621-626.
80. Thomsen LL, Lawton FG, Knowles RG, et al. Nitric oxide synthase activity in human gynecological cancer. Cancer Res 1994;54:1352-1354.
81. Cobbs CS, Brenma JE, Aldape KD, et al. Expression of nitric oxide synthase in human central nervous system tumors. Cancer Res 1995;55:727-730.
82. Thomsen LL, Miles DW, Happerfield L, et al. Nitric oxide synthase activity in human breast cancer. Br J Cancer 1995;72:41-44.
83. Thomsen LL, Miles DW, Happerfield L, et al. Nitric oxide synthase activity in human breast cancer. Proc Amer Assoc Cancer Res 1995;36:503.
84. Edwards P, Cedan JC, Topping DB, et al. Tumor cell nitric oxide inhibits cell growth in vitro, but stimulates tumorigenesis and experimental lung metastasis in vivo. J Surg Res 1996;63:49-52.
85. Jenkins DC, Charles IG, Baylis SA, et al. Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation. Br J Cancer 1994;70:847-849.
86. Jenkins DC, Charles IG, Thomsen LL, et al. Roles of nitric oxide in tumor growth. Proc Natl Acad USA 1995; 82:4392-4396.
87. Xie K, Huang S, Dong Z, et al. Transfection with the inducible nitric oxide synthase gene suppresses tumorigenicity and abrogated metastasis by K-1735 murine melanoma cells. J Exp Med 1995;181:1333-1343.
88. Gaston B, Drazen JM, Loscalzo J, et al. The biology of nitrogen oxides in the air airways. Am J Respir Crit Care Med 1994;19:538-551.
89. Epperlein MM, Nourooz-Zadeh J, Noronha-Dutra AA, et al. Nitric oxide in cigarette smoke as a mediator of oxidative damage. Int J Exp Pathol 1996;77:197-200.
90. Mirvish SS. Role of N-nitroso compounds (NOC) and N-nitrosation in etiology of gastric, esophageal, nasopharyngeal and bladder cancer and contribution of known exposures to NOC. Cancer Lett 1995;93:17-113.
91. Bodis S, Haregewoin A. Evidence for the release and possible neural regulation of nitric oxide in human saliva. Biochem Biophys Res Comm 1993;194:347-350.
92. Bentz BG, Haines GK, Hanson DG, et al. Endothelial constitutive nitric oxide synthase (ecNOS) in normal and neoplastic salivary tissue. Head Neck 1998;20:304-309.
93. Yamane H, Takayama M, Konishi K, et al. Nitric oxide synthase and contractile protein in the rat cochlear lateral wall: possible role of nitric oxide in regulation of strial blood flow. Hearing Res 1997;108:65-73.
94. Amaee FR, Comis SD, Osborne MP, et al. Possible involvement of nitric oxide in the sensorineural hearing loss of bacterial meningitis. Acta Oto-Laryngol 1997;117: 329-336.
95. Ball SS, Prazma J, Dais CGD, et al. Nitric oxide: a mediator of endotoxin-induced middle ear effusions. Laryngoscope 1996;106:1018-1020.
96. Chen C, Nenov A, Skellett R, et al. Nitroprusside suppresses cochlear potentials and outer hair cell responses. Hearing Res 1995;87:1-8.
97. Harper A, Blythe WR, Zdanski CJ, et al. Nitric oxide in the rat vestibular system. Oto Head Neck Surg 1994;111: 430-438.
98. Rabin BM. Free radicals and taste aversion learning in the rat: nitric oxide, radiation, and dopamine. Prog Neuro-Psychopharm Biol Psych 1996:20:691-707.
99. Breer H, Shepherd GM. Implication of the NO/cGMP system for olfaction. TINS 1993;16:5-9.
100. Michel O, Bloch W, Rocker J, et al. NOS-mapping of human nasal mucosa under physiologic and pathophysiological conditions. In: Moncada S, Stamler J, Gross S, Higgs EA, editors. The biology of nitric oxide, part 5. proceeding of the fourth international meeting on the biology of nitric oxide. London: Portland Press; 1996. p 230.
101. Lane AP, Prazma J, Baggett HC, et al. Nitric oxide is a mediator of neurogenic vascular exudation in the nose. Oto-Head Neck Surg 1997;116:294-300.
102. Lundberg JO, Weitzberg E, Rinder J, et al. Calcium-independent and steroir-resistant nitric oxide synthase activity in human paranasal sinus mucosa. Eur Resp J 1996;9:1344-1347.
103. Lindberg S, Cervin A, Runer T. Nitric oxide (NO) production in the upper airways is decreased in chronic sinusitis. Acta Oto-Laryngol 1997;117:113-117.
104. Brandsma JL, Abramson AL. Association of papillomavirus with cancers of the head and neck. Arch Otolaryngol Head Neck Surg 1989;115:621.
105. Marshall JR, Graham S, Haughey BP, et al. Smoking, alcohol, dentition, and diet in the epidemiology of oral cancer. Eur J Cancer 1992;28B:9-15.
106. Beyer JD, Pape HD. The etiology of carcinoma of the mouth mucosa from exogenous continuous irritation. Deutsche Zahnarztliche Zeitschrift 1977;32:611-612.
107. Rosbe KW, Prazma J, Petrusz P, et al. Immunohistochemical characterization of nitric oxide synthase activity in squamous cell carcinoma of the head and neck. Oto Nead neck surg 1995;113:541-549
108. Bentz BG, Haines GK, Lingen, MW, et al. Nitric oxide synthase type 3 is increased in squamous hyperplasia, dysplasia, and squamous cell carcinoma of the head and neck. Ann Oto Rhinol Laryngol 1999;108:781-787.
109. Bentz BG, Haines GK, Radosevich JA. Increased protein nitrosylation in head and neck squamous cell carcinoma. Head Neck (Accepted for publication).
110. Gallo O, Masini E, Morbidelli L, et al. Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer. J Natl Cancer Inst 1998;90:587-96.
111. Galvilanes J, Moro MA, Lizasoain I, et al. Nitric oxide synthase activity in human squamous cell carcinoma of the head and neck. Laryngoscope 1999;109:148-152.
112. Liu R, Oberley TD, Oberley LW. Effects of endothelial nitric oxide synthase gene expression on the tumor biology of human oral carcinoma SCC-25 cells. Cell Growth Diff 1998;9:239-246.
113. Calmels S, Hainaut P, Ohshima H. Nitric oxide induces conformational and functional modifications of wild-type p53 tumor suppressor protein. Cancer Res 1997;57: 3365-369.
114. Delaney CA, Green MHL, Lowe JE, et al. Endogenous nitric oxide induced by interleukin-1β in rat islets of Langerhans and HIT-T15 cells causes significant DNA damage as measured by the "comet" assay. FEBS 1993; 333:291-295.
115. Vasenwala SM, Aziz M, Rattan A, et al. Immunologic status of patients with carcinoma of the head and neck. Indian J Cancer 1989;26:137-144.
116. Horst HA, Horny HP. Tumor-infiltrating lymphoreticular cells: histologic and immunohistologic investigations performed on metastasizing squamous cell carcinomas of the head and neck. Cancer 1991;68:2397-2402.
117. Karmali RA, Wustrow T, Thaler HT, et al. Prostaglandins in carcinomas of the head and neck. Cancer Lett 1984;22:333-336.
118. Plescia OJ, Smith AH, Grinwich K. Subversion of immune system by tumor cells and role of prostaglandins. Proc Natl Acad Sci USA 1975;72:1848-1851.
119. Ceuppens J, Goodwin J. Prostaglandins and the immune response to cancer, [review] Anticancer Res 1981;1: 71-78.
120. Evans DM, Ralston SH. Nitric oxide and bone. J Bone Mineral Res 1996;11:300-305.
121. Murrell GA, Jang D, Williams RJ. Nitric oxide activates metalloprotease enzymes in articular cartilage. Biochem biophys Res Comm 1995;206:15-21.
122. Stefanovic-Racic M, Morales TI, Taskiran D, et al. The role of nitric oxide in proteoglycan turnover by bovine articular cartilage organ cultures. J Immunol 1996;156: 1213-1220.
123. Charous SJ, Stricklin GP, Nanney LB, et al. Expression of matrix metalloproteinases and tissue inhibitor of metalloproteinases in head and neck squamous cell carcinoma. Ann Otol Rhinol Laryngnol 1997;106:271-278.
124. Keane JJ, Hawkins NV, Beale FA, et al. Carcinoma of the hypophaynx: results of primary radical irradiation therapy. Int J Radiat Oncol Biol Phys 1982;9:659-664.
125. Lefebvre JL, Adenis L, Ton-Van J, et al., Is laryngeal preservation with induction chemotherapy safe in the treatment of hypopharynx squamous cell carcinoma? preliminary results of a randomized trial (meeting abstract). Paper presented at the Third International Head and Neck Oncology Research Conference and the American Society for Head and Neck Surgery; September 27, 1990; Las Vegas, NV.